Caracciolo, M.; Castello, A.; Urso, L.; Borgia, F.; Ortolan, N.; Uccelli, L.; Cittanti, C.; Castellani, M.; Bartolomei, M.; Lazzeri, M.;
et al. The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review. Cancers 2022, 14, 5036.
https://doi.org/10.3390/cancers14205036
AMA Style
Caracciolo M, Castello A, Urso L, Borgia F, Ortolan N, Uccelli L, Cittanti C, Castellani M, Bartolomei M, Lazzeri M,
et al. The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review. Cancers. 2022; 14(20):5036.
https://doi.org/10.3390/cancers14205036
Chicago/Turabian Style
Caracciolo, Matteo, Angelo Castello, Luca Urso, Francesca Borgia, Naima Ortolan, Licia Uccelli, Corrado Cittanti, Massimo Castellani, Mirco Bartolomei, Massimo Lazzeri,
and et al. 2022. "The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review" Cancers 14, no. 20: 5036.
https://doi.org/10.3390/cancers14205036
APA Style
Caracciolo, M., Castello, A., Urso, L., Borgia, F., Ortolan, N., Uccelli, L., Cittanti, C., Castellani, M., Bartolomei, M., Lazzeri, M., & Lopci, E.
(2022). The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review. Cancers, 14(20), 5036.
https://doi.org/10.3390/cancers14205036
